Stroke, Vol 25, 457-464, Copyright © 1994 by American Heart Association
JJ Vornov, RC Tasker and JT Coyle
BACKGROUND AND PURPOSE: The hippocampus demonstrates a regional pattern of
vulnerability to ischemic injury that depends on its characteristic
differentiation and intrinsic connections. We now describe a model of
ischemic injury using organotypic hippocampal culture, which preserves the
anatomic differentiation of the hippocampus in long-term tissue culture.
METHODS: Ischemic conditions were modeled by metabolic inhibition. Cultures
were briefly exposed to potassium cyanide to block oxidative
phosphorylation and 2-deoxyglucose to block glycolysis. The fluorescent dye
propidium iodide was used to observe membrane damage in living cultures
during recovery. RESULTS: 2-Deoxyglucose/potassium cyanide incubation
resulted in dose-dependent, regionally selective neuronal injury in CA1 and
the dentate hilus, which began slowly after 2 to 6 hours of recovery.
Subsequent histological examination of cultures after 1 to 7 days of
recovery demonstrated neuronal pyknosis that was correlated with the early,
direct observation of membrane damage with propidium. Both propidium
staining and histological degeneration were prevented by the noncompetitive
N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 when administered 30
minutes after the end of the exposure to 2-deoxyglucose and potassium
cyanide. Tetrodotoxin, which blocks voltage-dependent sodium channels, had
protective effects that were greatest during the period of 2- deoxyglucose
and potassium cyanide incubation but also produced protection against the
mildest conditions of metabolic inhibition when administered after 30
minutes of recovery. CONCLUSIONS: This in vitro model reproduced elements
of the time course, regional vulnerability, and pharmacologic sensitivities
of in vivo ischemic hippocampal injury. Inhibition of metabolism in
organotypic culture provides a rapid, easily controlled injury and
reproduces the in vitro pattern of hippocampal regional vulnerability to
ischemia. It is the first in vitro model of ischemia to exhibit complete
protection by delayed administration of an NMDA receptor antagonist during
recovery from a brief insult. The protective effects of tetrodotoxin
suggest that an early period of sodium entry into cells during and after
ATP depletion may be responsible for the more prolonged period of toxic
NMDA receptor activation.
ARTICLES
Delayed protection by MK-801 and tetrodotoxin in a rat organotypic hippocampal culture model of ischemia
Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Md.
This article has been cited by other articles:
![]() |
C. R. Elliott-Hunt, B. Marsh, A. Bacon, R. Pope, P. Vanderplank, and D. Wynick Galanin acts as a neuroprotective factor to the hippocampus PNAS, April 6, 2004; 101(14): 5105 - 5110. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Winter, A. K Pringle, G. F. Clough, and M. K. Church Raised parenchymal interleukin-6 levels correlate with improved outcome after traumatic brain injury Brain, February 1, 2004; 127(2): 315 - 320. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Barone, E. A. Irving, A. M. Ray, J. C. Lee, S. Kassis, S. Kumar, A. M. Badger, R. F. White, M. J. McVey, J. J. Legos, et al. SB 239063, a Second-Generation p38 Mitogen-Activated Protein Kinase Inhibitor, Reduces Brain Injury and Neurological Deficits in Cerebral Focal Ischemia J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 312 - 321. [Abstract] [Full Text] |
||||
![]() |
K.-A. Hossmann Experimental models for the investigation of brain ischemia Cardiovasc Res, July 1, 1998; 39(1): 106 - 120. [Full Text] [PDF] |
||||
![]() |
J. Hill Lucas, D. G. Emery, and L. J. Rosenberg REVIEW {blacksquare} : Physical Injury of Neurons: Important Roles for Sodium and Chloride Ions Neuroscientist, March 1, 1997; 3(2): 89 - 101. [Abstract] [PDF] |
||||
![]() |
A.K. Pringle, C.D. Benham, L. Sim, J. Kennedy, F. Iannotti, L.E. Sundstrom, and D. W. Choi Selective N-Type Calcium Channel Antagonist Omega Conotoxin MVIIA Is Neuroprotective Against Hypoxic Neurodegeneration in Organotypic Hippocampal-Slice Cultures Stroke, November 1, 1996; 27(11): 2124 - 2130. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |